MSD

Korean chipmakers Samsung strives to prevent musculoskeletal disorders in the workplace

Samsung Electronics Co., the world’s largest memory chipmaker, is striving to prevent musculoskeletal disorders (MSDs) in its workplace to imp...

Bio & Pharma Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials

Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...

Bio & Pharma Hanmi Pharm's Efinopegdutide gets Fast Track Designation from FDA

Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...

Bio & Pharma SK Bioscience to produce MSD’s new Ebola vaccine candidate

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a contract with MSD, a global pharma...

Cell therapy GC Lab Cell, Artiva ink $1.9 bn deal with MSD

South Korea-based biotechnology company Green Cross Lab Cell Corp. (GC Lab Cell) and its US-based subsidiary have inked a $1.9 billion deal to expor...